Per Simply Wall ST, 08/31/2024: “AbCellera Biologics Inc. (NASDAQ:ABCL) shareholders (or potential shareholders) will be happy to see that the CEO, President & Chairperson, Carl Hansen, recently bought a whopping US$740k worth of stock, at a price of US$2.61. There's no denying a buy of that magnitude suggests conviction in a brighter future, although we do note that proportionally it only increased their holding by 0.5%.”
I bought some shares before COVID blew up, assuming the obvious was going to happen. But then it crashed, losing me over 70% of my invested value. Thankfully it was a drop in the bucket compared to the rest of my portfolio. I never sold, so it's still showing on my dashboard and I revisited it this week. I bought around 20 shares at a few dollars each this week, so we'll see what happens. I'm not holding my breath.
Leave a Reply